LYTIR

Company · NTNX

Nutanix, Inc.

Nasdaq's symbol directory lists NTNX on Nasdaq as “Nutanix, Inc. - Class A Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 6 occasions ($54.5M); 6 planned-sale notices; 1 filing by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 24, No. 23, No. 22, No. 21, No. 20, No. 19, No. 18, No. 17

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $54.5M in total.Sep: Insider sales $7.4MOct: Insider sales $47.1MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $54.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. RAMASWAMI RAJIV, Chief Executive Officer sold on 2 days all under a 10b5-1 plan latest Oct 7, 2026 sold $29.5M
  2. Sivaraman Rukmini, Chief Financial Officer sold on 2 days all under a 10b5-1 plan latest Oct 12, 2026 sold $20.0M
  3. Maner Tarkan, President and CCO sold on 1 day latest Sep 24, 2026 sold $4.8M
  4. Sheppard Teresa Gayle sold on 1 day all under a 10b5-1 plan latest Oct 9, 2026 sold $258K
Every trade (6)
  1. SELLSivaraman Rukmini, Chief Financial Officer sold Oct 12, 2026 232,712 shares 2 legs combined 10b5-1 plan (scheduled) filing $17.3M
  2. SELLSheppard Teresa Gayle sold Oct 9, 2026 3,500 shares 2 legs combined 10b5-1 plan (scheduled) filing $258K
  3. SELLRAMASWAMI RAJIV, Chief Executive Officer sold Oct 7, 2026 75,045 shares 10b5-1 plan (scheduled) filing $5.6M
  4. SELLRAMASWAMI RAJIV, Chief Executive Officer sold Oct 6, 2026 324,955 shares 2 legs combined 10b5-1 plan (scheduled) filing $23.9M
  5. SELLManer Tarkan, President and CCO sold Sep 24, 2026 69,778 shares filing $4.8M
  6. SELLSivaraman Rukmini, Chief Financial Officer sold Sep 17, 2026 38,139 shares 10b5-1 plan (scheduled) filing $2.7M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. RUKMINI N SIVARAMAN filed Oct 13, 2026 Officer 232,712 shares planned sale date 10/12/2026 filing $17.3M
  2. TERESA GAYLE SHEPPARD filed Oct 9, 2026 Director 3,500 shares planned sale date 10/09/2026 filing $258K
  3. RAJIV RAMASWAMI filed Oct 7, 2026 Officer 75,045 shares planned sale date 10/07/2026 filing $5.6M
  4. RAJIV RAMASWAMI filed Oct 6, 2026 Officer 324,955 shares planned sale date 10/06/2026 filing $23.9M
  5. TARKAN MANER filed Sep 24, 2026 Officer 69,778 shares planned sale date 09/24/2026 filing $4.8M
  6. RUKMINI N SIVARAMAN filed Sep 17, 2026 Officer 38,139 shares planned sale date 09/17/2026 filing $2.7M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Vanguard Portfolio Management filed Jul 31, 2026 Schedule 13G/A passive 13,440,444 shares filing 4.97%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers filing Oct 7, 2026
  2. Departure or appointment of directors or officers filing Sep 24, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.